APA (7th ed.) Citation

Wick, A., Keßler, T., Platten, M., Meisner, C., Bamberg, M., Herrlinger, U., . . . Wick, W. (2020). Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma. Neuro-Oncology, 22(8), . https://doi.org/10.1093/neuonc/noaa033

Chicago Style (17th ed.) Citation

Wick, Antje, et al. "Superiority of Temozolomide over Radiotherapy for Elderly Patients with RTK II Methylation Class, MGMT Promoter Methylated Malignant Astrocytoma." Neuro-Oncology 22, no. 8 (2020). https://doi.org/10.1093/neuonc/noaa033.

MLA (9th ed.) Citation

Wick, Antje, et al. "Superiority of Temozolomide over Radiotherapy for Elderly Patients with RTK II Methylation Class, MGMT Promoter Methylated Malignant Astrocytoma." Neuro-Oncology, vol. 22, no. 8, 2020, https://doi.org/10.1093/neuonc/noaa033.